Obesity Impacts Mortality and Rate of Revascularizations Among Patients With Acute Myocardial Infarction: An Analysis of the National Inpatient Sample.

acute myocardial infarction cardiovascular disease nis obesity obesity paradox

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
04 Dec 2020
Historique:
entrez: 11 1 2021
pubmed: 12 1 2021
medline: 12 1 2021
Statut: epublish

Résumé

Background Obesity is now a recognized chronic comorbid condition which is highly prevalent in the United States. Obesity poses several health risks, affecting multiple organ systems. The cardiovascular system is particularly affected by obesity including its role in atherosclerotic disease and hence myocardial infarction (MI) from atheromatous plaque events. However, multiple population-based studies have shown mixed outcomes in obese patients who have acute MI. This study aimed to determine if obesity paradoxically improved outcomes in patients with acute myocardial infarction (AMI) as well as compare outcomes of mild to moderately obese patients and morbidly obese patients to non-obese patients. Materials and methods Data was obtained from the Nationwide Inpatient Sample (NIS) for 2016 and 2017. The study included adult patients with a principal discharge diagnosis of AMI. This group was divided into ST segment elevation myocardial infarction (STEMI) and non-ST segment myocardial infarction (NSTEMI). Obese patients were subdivided into two groups: mild-moderate obesity and morbid obesity. Primary outcome compared inpatient mortality. Secondary outcomes included rate of percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), composite revascularization, mean length of hospitalization, total hospital charges, and rates of complications. Results In patients with STEMI, mild to moderately obese patients had lower odds of mortality (aOR: 0.80, 95% CI: 0.715-0.906, p < 0.001) compared to non-obese patients. However, morbidly obese patients had higher odds of mortality (aOR: 1.26, 95% CI: 1.100-1.446, p < 0.001) compared to non-obese patients. Mild to moderately obese patients had higher odds of composite revascularization (aOR: 1.24, 95% CI: 1.158-1.334, p < 0.001), PCI (aOR: 1.08, 95% CI: 1.054-1.150, p = 0.014), and CABG (aOR: 1.46, 95% CI: 1.313-1.626, p < 0.001). Conclusion The degree of obesity affects outcome of patients with AMI. Cardiovascular interventions during hospitalizations for AMI also varied with degree of obesity. This may have affected the outcome, especially among morbidly obese patients.

Identifiants

pubmed: 33425499
doi: 10.7759/cureus.11910
pmc: PMC7785489
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e11910

Informations de copyright

Copyright © 2020, Velazquez et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Am Acad Dermatol. 2020 Nov 2;:
pubmed: 33152368
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
NCHS Data Brief. 2015 Nov;(219):1-8
pubmed: 26633046
Eur J Intern Med. 2018 Feb;48:6-17
pubmed: 29100895
JAMA. 2018 Apr 24;319(16):1723-1725
pubmed: 29570750
J Intensive Care Med. 2005 May-Jun;20(3):147-54
pubmed: 15888902
Minerva Med. 2017 Jun;108(3):212-228
pubmed: 28150485
Am Heart J. 2006 Jul;152(1):140-8
pubmed: 16824844
Cureus. 2020 Sep 4;12(9):e10241
pubmed: 33042681
Intensive Care Med. 2008 Nov;34(11):1999-2009
pubmed: 18670756
J Am Coll Cardiol. 2009 May 26;53(21):1925-32
pubmed: 19460605
Cureus. 2020 Jun 29;12(6):e8902
pubmed: 32742869
J Am Heart Assoc. 2017 Sep 22;6(9):
pubmed: 28939712
J Clin Rheumatol. 2020 Sep 16;:
pubmed: 32947436
Am J Cardiol. 2013 Apr 15;111(8):1104-10
pubmed: 23360768
J Clin Rheumatol. 2020 Sep 10;:
pubmed: 32925445
J Am Coll Cardiol. 2011 Dec 13;58(25):2642-50
pubmed: 22152950
Cureus. 2020 Aug 17;12(8):e9799
pubmed: 32953311
Cureus. 2020 Jul 12;12(7):e9155
pubmed: 32789091
Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68
pubmed: 18327995
Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):537-47
pubmed: 26826295

Auteurs

Genaro Velazquez (G)

Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, USA.

Trisha Marie A Gomez (TMA)

Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, USA.

Iriagbonse Asemota (I)

Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, USA.

Emmanuel Akuna (E)

Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, USA.

Pius E Ojemolon (PE)

Anatomical Sciences, St. George's University, St. George's, GRD.

Precious Eseaton (P)

Internal Medicine, College of Medicine, University of Benin, Benin City, NGA.

Classifications MeSH